Interaction between angiotensin-converting enzyme genotype and glycaemic control influences lipoprotein levels in Type 2 diabetes mellitus

Wiener Klinische Wochenschrift

Volumn 115, Issue 1-2, 2003, Pages 36-40

  Tkáč, Ivan ^a,c   Šalagovič, Ján ^a   Kozárová, Miriam ^a   Rosolová, Hana ^b   Molčányiová, Angela ^c   Mosorjáková, Dana ^a   Chleborádová, Martina ^a   Kalina, Ivan ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b CHARLES UNIVERSITY   (Czech Republic)

^c FACULTY HOSPITAL   (Slovakia)

Author keywords

Angiotensin converting enzyme polymorphism; Apolipoprotein B; Glycated haemoglobin; Lipoproteins; Type 2 diabetes mellitus

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; HEMOGLOBIN A1C; LIPOPROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION;

EID: 0345772107     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03040270     Document Type: Article

References (30)

1. Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The Framingham study. J Am Med Assoc 241: 2035-2038
2. Reaven GM (1994) Syndrome X: 6 years later. J Intern Med 736 [Suppl]: 13-22
3. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M, et al (1994) Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43: 384-388
4. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J-P, Arveiler D, et al (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 461-464
5. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D, et al (1994) Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91: 3662-3665
6. Jeffers BW, Estacio RO, Raynolds MV, Schrier RW (1997) Angiotensin-converting enzyme polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney Int 52: 473-477
7. Barnas U, Schmidt A, Illievich A, Kiener HP, Rabensteiner D, Kaider A, et al (1997) Evaluation of risk for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control. Diabetologia 40: 327-331
8. Huang XH, Rantalaiho V, Wirta O, Pasternack A, Koivula T, Hiltunen T, et al (1998) Relationship of the angiotensinconverting enzyme gene polymorphism to glucose intolerance, insulin resistance, and hypertension in NIDDM. Hum Genet 102: 372-378
9. Sertic J, Hebrang D, Janus D, Salzer B, Niksic M, Cvoriscec D, et al (1996) Association between deletion polymorphism of the angiotensin-converting enzyme and cerebral atherosclerosis. Eur J Clin Chem Clin Biochem 34: 301-304
10. Oren I, Brook JG, Gershoni-Baruch R, Kepten I, Tamir A, Linn S, et al (1999) The D allele of the angiotensin-converting enzyme gene contributes toward blood LDL-cholesterol levels and the presence of hypertension. Atherosclerosis 145: 267-271
11. Katsuya T, Horiuchi M, Chen YDI, Koike G, Pratt RE, Dzau VJ, et al (1995) Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia. Arterioscler Thromb Vasc Biol 15: 779-782
12. Corbo RM, Vilardo T, Mantuano E, Ruggeri M, Gemma AT, Scacchi R (1999) Apolipoproteins B and E, and angiotensin I-converting enzyme genetic polymorphisms in Italian women with coronary artery disease (CAD) and their relationships with plasma lipid and apolipoprotein levels. Hum Biol 71: 933-945
13. Kobayashi K, Amemiya S, Mochizuki M, Kobayashi K, Matsushita K, Sawanabori E, et al (1999) Association of angiotensin-converting enzyme gene polymorphism with lipid profiles in children and adolescents with insulin-dependent diabetes mellitus. Horm Res 51: 201-204
14. Nagi DK, Foy CA, Mohamed-Ali V, Yudkin JS, Grant PJ, Knowler WC (1998) Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians. Metabolism 47: 622-626
15. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, et al (1998) Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). Br Med J 316: 823-828
16. Howard BV, Robbins DC, Sievers ML, Lee ET, Rhoades D, Devereux RB, et al (2000) LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL. The Strong Heart Study. Arterioscler Thromb Vasc Biol 20: 830-835
17. Wagner AM, Perez A, Calvo F, Bonet R, Castellvi A, Ordonez J (1999) Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients. Diabetes Care 22: 812-817
18. Lamarche B, Tchernof A, Mauriege P, Cantin B, Dagenais GR, Lupien PJ, et al (1998) Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA - J Am Med Assoc 279: 1955-1961
19. Tkáč I, Kimball BP, Lewis G, Uffelman K, Steiner G (1997) The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles. Arterioscler Thromb Vasc Biol 17: 3633-3638
20. Tkáč I, Mudríková T, Szabóová E, Ďurovcová E, Lewis GF (2001) Carotid intima-media thickness in type 2 diabetes is more strongly related to serum apoprotein A-I in females. Wien Klin Wochenschr 113: 194-198
21. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme accounted for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346
22. Duvillard L, Pont F, Florentin E, Gambert P, Verges B (2000) Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus. Diabetologia 43: 27-35
23. Cummings MH, Watts GF, Umpleby AM, Hennessy TR, Naoumova R, Slavin BM, et al (1995) Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetologia 38: 959-967
24. Steiner G, Tkáč I, Uffelman KD, Lewis GF (1998) Important contribution of lipoprotein particle number to plasma triglyceride concentration in type 2 diabetes. Atherosclerosis 137: 211-214
25. Tomkin GH, Owens D (2001) Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis. Diabetes Metab Res Rev 17: 27-43
26. Marian AJ, Safavi F, Ferlic L, Dunn JK, Gotto AM, Ballantyne CM (2000) Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin. The Lipoprotein and Coronary Atherosclerosis Study. J Am Coll Cardiol 35: 89-95
27. Mattei MG, Hubert C, Alhenc-Gelas F, Roeckel N, Corvol P, Soubrier F (1989) Angiotensin-I converting enzyme gene is on chromosome 17. Cytogenet Cell Genet 51: 1041
28. Haagerup A, Kristensen T, Kruse TA (1991) Polymorphism and genetic mapping of the gene encoding human beta-2-glycoprotein I to chromosome 17. Cytogenet Cell Genet 58: 2005
29. Ruiu G, Gambino R, Veglia F, Pagano G, Cassader M (1997) Influence of APOH protein polymorphism on apoH levels in normal and diabetic subjects. Clin Genet 52: 167-172
30. Mehdi H, Aston CE, Sanghera DK, Hamman RF, Kamboh MI (1999) Genetic variation in the apolipoprotein H (beta2-glycoprotein I) gene affects plasma apolipoprotein H concentrations. Hum Genet 105: 63-71